Commerce Preliminary Antidumping Duty Investigation of CBS from the People’s Republic of China
Preliminary Affirmative Determination in the Antidumping Duty Investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from the People’s Republic of China
On November 4, 2026, the U.S. Department of Commerce (Commerce) announced its preliminary affirmative determination in the antidumping duty (AD) investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from the People’s Republic of China (China).
Preliminary Dumping Rates
China
| Producer | Exporter | Weighted-Average Dumping Margins (percent) | Cash Deposit Rates (Adjusted for Subsidy Offsets) (percent) |
|---|---|---|---|
| China-Wide Entity | 285.94* | 281.69 | |
*Rate based on facts available with adverse inferences.
Next Steps
- Based on the signature date of this preliminary determination, the final determination of the AD investigation should be announced on or around January 12, 2027.
- The U.S. International Trade Commission (ITC) is conducting concurrent injury determination investigations. For more information related to the ITC’s timeline, please refer to the ITC’s calendar.
- Commerce is also conducting concurrent countervailing duty (CVD) investigation of CBS from China
Other Case Information
- The is LANXESS Corporation (Pittsburgh, PA).
- For general information and next steps, please refer to a list of preliminary FAQs.
- Additional case information, including the scope of the investigations, are on file electronically via Enforcement and Compliance’s Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). Once you log in, please refer to the following case number A-570-234.
- To date, Commerce maintains 854 AD and CVD orders that provide relief to American companies and industries impacted by unfair trade.